Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022:32:100619.
doi: 10.1016/j.ctarc.2022.100619. Epub 2022 Aug 6.

Racial disparities in treatments and mortality among a large population-based cohort of older men and women with colorectal cancer

Affiliations

Racial disparities in treatments and mortality among a large population-based cohort of older men and women with colorectal cancer

Xianglin L Du et al. Cancer Treat Res Commun. 2022.

Abstract

Background: There were racial disparities in treatment and mortality among patients with colorectal cancer, but few studies incorporated information on hypertension and diabetes and their treatment status.

Patients and methods: The study identified 101,250 patients from Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database in the United States who were diagnosed with colorectal cancer at age ≥65 years between 2007 and 2015 with follow-up to December 2016.

Results: There were substantial racial and ethnic disparities in the prevalence of hypertension and diabetes in patients with colorectal cancer, in receiving chemotherapy and radiation therapy, and in receiving antihypertensive and antidiabetic treatment. Racial disparities in receiving these therapies remained significant in this large cohort of Medicare beneficiaries after stratifications by private health insurance status at the time of cancer diagnosis and by tumor stage. Non-Hispanic black patients had a significantly higher risk of all-cause mortality (hazard ratio: 1.07, 95% CI: 1.04-1.10), which remained significantly higher (1.05, 1.02-1.08) after adjusting for patient sociodemographics, tumor factors, comorbidity and treatments as compared to non-Hispanic white patients. The adjusted risk of colorectal cancer-specific mortality was also significantly higher (1.08, 1.04-1.12) between black and white patients.

Conclusions: There were substantial racial disparities in prevalence of hypertension and diabetes in men and women diagnosed with colorectal cancer and in receipt of chemotherapy, radiation therapy, antihypertensive and antidiabetic treatment. Black patients with colorectal cancer had a significantly higher risk of all-cause mortality and colorectal cancer-specific mortality than whites, even after adjusting for sociodemographic characteristics, tumor factors, comorbidity scores, and treatments.

Keywords: Cancer treatment; Colorectal cancer; Diabetes; Hypertension; Racial disparities; SEER areas.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Similar articles

Cited by

References

    1. Page WF, Kuntz AJ, Racial and socioeconomic factors in cancer survival. A comparison of Veterans Administration results with selected studies, Cancer 45 (1980) 1029–1040. - PubMed
    1. Wegner EL, Kolonel LN, Nomura AM, et al. , Racial and socioeconomic status differences in survival of colorectal cancer patients in Hawaii, Cancer 49 (1982) 2208–2216. - PubMed
    1. Dayal H, Polissar L, Yang CY, Race DS, socioeconomic status, and other prognostic factors for survival from colo-rectal cancer, J. Chronic. Dis 40 (1987) 857–864. - PubMed
    1. Akerley WL 3rd, Moritz TE, Ryan LS, et al. , Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer, Arch. Intern. Med. 153 (1993), 1681–8. - PubMed
    1. Mayberry RM, Coates RJ, Hill HA, et al. , Determinants of black/white differences in colon cancer survival, J. Natl. Cancer Inst. 87 (1995) 1686–1693. - PubMed

Publication types

Substances